Reata Pharmaceuticals Inc
RETADelisted Sep 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001358762
Reata Pharmaceuticals Inc was delisted on Sep 26, 2023; its insiders filed their last Form 4 on Sep 28, 2023; 214 institutions reported holding it in 13F filings for Q2 2023, worth $3.21B in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Reata Pharmaceuticals Inc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
RETA is no longer listed, and 13F filings after Q2 2023 list far fewer holders. See Q2 2023
- Institutional holders
- 0
- −2 vs. Q3 2023
- Shares held
- 0
- −17.3K (−100.0%) vs. Q3 2023
- Total value
- $0
- −$2.98M (−100.0%) vs. Q3 2023
- New holders
- 0
- 0 more added
- Sold out
- 2
- 0 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RETA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 2 | $2.98M |
| Q2 2023 | 214 | $3.21B |
| Q1 2023 | 205 | $2.58B |
| Q4 2022 | 168 | $1.14B |
| Q3 2022 | 159 | $706.1M |
| Q2 2022 | 147 | $841.1M |
| Q1 2022 | 149 | $884.1M |
| Q4 2021 | 151 | $704.3M |
| Q3 2021 | 183 | $2.69B |
| Q2 2021 | 195 | $3.76B |
| Q1 2021 | 201 | $2.52B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Reata Pharmaceuticals Inc; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −300−100.0% | Sold out |